White paper: Choosing an FDA-Cleared Wearable for Your Clinical Trial

FDA clearance is an important distinguishing factor between medical and consumer devices, but choosing digital health technologies (DHTs) for clinical trials carries various other nuances. This paper presents a list of criteria that sponsors should consider beyond the FDA label to select the right data collection platform for their next trial, and explains how EmbracePlus and the Empatica Health Monitoring Platform meet those criteria.

What's inside:

• Design factors to consider
• What guarantees data quantity & quality
• What Clinical Services and Operations to look for